Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Lipari Mining and SpurChain Partner to Tokenize Natural Diamond Production (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Sirona Biochem Corp V.SBM.H

Alternate Symbol(s):  SRBCF

Healthcare Biotechnology
Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with proprietary platform technology. It specializes in stabilizing carbohydrate molecules. It is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well... see more

Recent & Breaking News (TSXV:SBM.H)

Sirona Biochem Update to Shareholders on Financial Status and Operations

GlobeNewswire August 1, 2025

Sirona Biochem Announces Debenture Financing

GlobeNewswire April 22, 2025

Sirona Biochem Secures Strategic Investment Agreements and New Joint Venture with Promura GmbH

GlobeNewswire April 22, 2025

Canadian Investment Regulatory Organization Trading Halt - SBM

Canada NewsWire March 7, 2025

Sirona Biochem Showcases TFC-1326 in Stonegate Healthcare's Landmark Report

GlobeNewswire January 15, 2025

Sirona Biochem Announces Publication of Groundbreaking Study on TFC-1326 Compound in the Journal of Cosmetic Dermatology

GlobeNewswire November 20, 2024

Three high-quality micro-cap stocks for your coffee-can portfolio

Trevor Abes  October 4, 2024

SIRONA BIOCHEM Poised for Profitability in 2025 with Anti-Aging Product Rollout

GlobeNewswire September 25, 2024

GlycoProteMim Featured in Stonegate Healthcare's Latest Anti-Aging Research Report

GlobeNewswire June 18, 2024

Stonegate Healthcare Partners Announces Publication of Thematic Report on Anti-Aging Dermatology Innovations

Newsfile June 18, 2024

Sirona Biochem Engages Stonegate Healthcare Partners

GlobeNewswire May 7, 2024

SIRONA BIOCHEM Corporate Update April 2024

GlobeNewswire April 8, 2024

Sirona Biochem Announces Close of Private Placement

GlobeNewswire April 4, 2024

Sirona Biochem Announces 2023 Annual Meeting Results

GlobeNewswire March 28, 2024

Sirona Biochem Receives Commercial-Grade GlycoProteMim Based Anti-Aging Serum Formulations

GlobeNewswire March 13, 2024

Sirona Biochem Announces Plans for Commercial Launch of GlycoProteMim(TM) in Early 2025

GlobeNewswire February 21, 2024

Sirona Biochem Provides Update on Loan

GlobeNewswire February 15, 2024

Sirona Biochem Engages Global Beauty Consulting

GlobeNewswire February 15, 2024

Sirona Biochem Announces Loan

GlobeNewswire January 29, 2024

Sirona Biochem Initiates Private Placement

GlobeNewswire January 26, 2024